COVID-19 Impact on Global Biosimilars, Market Insights and Forecast to 2026
Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biosimilars market is segmented into
The Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars Market Share Analysis
Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars business, the date to enter into the Biosimilars market, Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Biosimilars market is segmented into
- Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
- Peptides (Glucagon, Calcitonin)
- Oncology
- Blood Disorders
The Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars Market Share Analysis
Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars business, the date to enter into the Biosimilars market, Biosimilars product introduction, recent developments, etc.
The major vendors covered:
- Pfizer
- Novartis
- Teva Pharmaceuticals Industries
- Amgen
- Biocon
- Dr. Reddy’s Laboratories
- Roche Holding
- Celltrion
- Samsung BioLogics
1 STUDY COVERAGE
1.1 Biosimilars Product Introduction
1.2 Market Segments
1.3 Key Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biosimilars Market Size Growth Rate by Type
1.4.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.4.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.4.4 Peptides (Glucagon, Calcitonin)
1.5 Market by Application
1.5.1 Global Biosimilars Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Blood Disorders
1.6 Coronavirus Disease 2019 (Covid-19): Biosimilars Industry Impact
1.6.1 How the Covid-19 is Affecting the Biosimilars Industry
1.6.1.1 Biosimilars Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biosimilars Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biosimilars Market Size Estimates and Forecasts
2.1.1 Global Biosimilars Revenue 2015-2026
2.1.2 Global Biosimilars Sales 2015-2026
2.2 Biosimilars Market Size by Region: 2020 Versus 2026
2.2.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL BIOSIMILARS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Biosimilars Sales by Manufacturers
3.1.1 Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 Biosimilars Revenue by Manufacturers
3.2.1 Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2019
3.2.5 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biosimilars Price by Manufacturers
3.4 Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biosimilars Market Size by Type (2015-2020)
4.1.1 Global Biosimilars Sales by Type (2015-2020)
4.1.2 Global Biosimilars Revenue by Type (2015-2020)
4.1.3 Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biosimilars Market Size by Application (2015-2020)
5.1.1 Global Biosimilars Sales by Application (2015-2020)
5.1.2 Global Biosimilars Revenue by Application (2015-2020)
5.1.3 Biosimilars Price by Application (2015-2020)
5.2 Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilars Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biosimilars by Country
6.1.1 North America Biosimilars Sales by Country
6.1.2 North America Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biosimilars Market Facts & Figures by Type
6.3 North America Biosimilars Market Facts & Figures by Application
7 EUROPE
7.1 Europe Biosimilars by Country
7.1.1 Europe Biosimilars Sales by Country
7.1.2 Europe Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilars Market Facts & Figures by Type
7.3 Europe Biosimilars Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Biosimilars by Region
8.1.1 Asia Pacific Biosimilars Sales by Region
8.1.2 Asia Pacific Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific Biosimilars Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Biosimilars by Country
9.1.1 Latin America Biosimilars Sales by Country
9.1.2 Latin America Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biosimilars Market Facts & Figures by Type
9.3 Central & South America Biosimilars Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Biosimilars by Country
10.1.1 Middle East and Africa Biosimilars Sales by Country
10.1.2 Middle East and Africa Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa Biosimilars Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biosimilars Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description, Business Overview and Total Revenue
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Biosimilars Products Offered
11.2.5 Novartis Recent Development
11.3 Teva Pharmaceuticals Industries
11.3.1 Teva Pharmaceuticals Industries Corporation Information
11.3.2 Teva Pharmaceuticals Industries Description, Business Overview and Total Revenue
11.3.3 Teva Pharmaceuticals Industries Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceuticals Industries Biosimilars Products Offered
11.3.5 Teva Pharmaceuticals Industries Recent Development
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description, Business Overview and Total Revenue
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Biosimilars Products Offered
11.4.5 Amgen Recent Development
11.5 Biocon
11.5.1 Biocon Corporation Information
11.5.2 Biocon Description, Business Overview and Total Revenue
11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biocon Biosimilars Products Offered
11.5.5 Biocon Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Corporation Information
11.6.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
11.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr. Reddy’s Laboratories Biosimilars Products Offered
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Roche Holding
11.7.1 Roche Holding Corporation Information
11.7.2 Roche Holding Description, Business Overview and Total Revenue
11.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche Holding Biosimilars Products Offered
11.7.5 Roche Holding Recent Development
11.8 Celltrion
11.8.1 Celltrion Corporation Information
11.8.2 Celltrion Description, Business Overview and Total Revenue
11.8.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Celltrion Biosimilars Products Offered
11.8.5 Celltrion Recent Development
11.9 Samsung BioLogics
11.9.1 Samsung BioLogics Corporation Information
11.9.2 Samsung BioLogics Description, Business Overview and Total Revenue
11.9.3 Samsung BioLogics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Samsung BioLogics Biosimilars Products Offered
11.9.5 Samsung BioLogics Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biosimilars Products Offered
11.1.5 Pfizer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Biosimilars Market Estimates and Projections by Region
12.1.1 Global Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biosimilars Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biosimilars Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Biosimilars Product Introduction
1.2 Market Segments
1.3 Key Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biosimilars Market Size Growth Rate by Type
1.4.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.4.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.4.4 Peptides (Glucagon, Calcitonin)
1.5 Market by Application
1.5.1 Global Biosimilars Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Blood Disorders
1.6 Coronavirus Disease 2019 (Covid-19): Biosimilars Industry Impact
1.6.1 How the Covid-19 is Affecting the Biosimilars Industry
1.6.1.1 Biosimilars Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biosimilars Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Biosimilars Market Size Estimates and Forecasts
2.1.1 Global Biosimilars Revenue 2015-2026
2.1.2 Global Biosimilars Sales 2015-2026
2.2 Biosimilars Market Size by Region: 2020 Versus 2026
2.2.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL BIOSIMILARS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Biosimilars Sales by Manufacturers
3.1.1 Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 Biosimilars Revenue by Manufacturers
3.2.1 Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2019
3.2.5 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biosimilars Price by Manufacturers
3.4 Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biosimilars Market Size by Type (2015-2020)
4.1.1 Global Biosimilars Sales by Type (2015-2020)
4.1.2 Global Biosimilars Revenue by Type (2015-2020)
4.1.3 Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biosimilars Market Size by Application (2015-2020)
5.1.1 Global Biosimilars Sales by Application (2015-2020)
5.1.2 Global Biosimilars Revenue by Application (2015-2020)
5.1.3 Biosimilars Price by Application (2015-2020)
5.2 Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilars Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biosimilars by Country
6.1.1 North America Biosimilars Sales by Country
6.1.2 North America Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biosimilars Market Facts & Figures by Type
6.3 North America Biosimilars Market Facts & Figures by Application
7 EUROPE
7.1 Europe Biosimilars by Country
7.1.1 Europe Biosimilars Sales by Country
7.1.2 Europe Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilars Market Facts & Figures by Type
7.3 Europe Biosimilars Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Biosimilars by Region
8.1.1 Asia Pacific Biosimilars Sales by Region
8.1.2 Asia Pacific Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific Biosimilars Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Biosimilars by Country
9.1.1 Latin America Biosimilars Sales by Country
9.1.2 Latin America Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biosimilars Market Facts & Figures by Type
9.3 Central & South America Biosimilars Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Biosimilars by Country
10.1.1 Middle East and Africa Biosimilars Sales by Country
10.1.2 Middle East and Africa Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa Biosimilars Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biosimilars Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description, Business Overview and Total Revenue
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Biosimilars Products Offered
11.2.5 Novartis Recent Development
11.3 Teva Pharmaceuticals Industries
11.3.1 Teva Pharmaceuticals Industries Corporation Information
11.3.2 Teva Pharmaceuticals Industries Description, Business Overview and Total Revenue
11.3.3 Teva Pharmaceuticals Industries Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceuticals Industries Biosimilars Products Offered
11.3.5 Teva Pharmaceuticals Industries Recent Development
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description, Business Overview and Total Revenue
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Biosimilars Products Offered
11.4.5 Amgen Recent Development
11.5 Biocon
11.5.1 Biocon Corporation Information
11.5.2 Biocon Description, Business Overview and Total Revenue
11.5.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biocon Biosimilars Products Offered
11.5.5 Biocon Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Corporation Information
11.6.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
11.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr. Reddy’s Laboratories Biosimilars Products Offered
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Roche Holding
11.7.1 Roche Holding Corporation Information
11.7.2 Roche Holding Description, Business Overview and Total Revenue
11.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche Holding Biosimilars Products Offered
11.7.5 Roche Holding Recent Development
11.8 Celltrion
11.8.1 Celltrion Corporation Information
11.8.2 Celltrion Description, Business Overview and Total Revenue
11.8.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Celltrion Biosimilars Products Offered
11.8.5 Celltrion Recent Development
11.9 Samsung BioLogics
11.9.1 Samsung BioLogics Corporation Information
11.9.2 Samsung BioLogics Description, Business Overview and Total Revenue
11.9.3 Samsung BioLogics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Samsung BioLogics Biosimilars Products Offered
11.9.5 Samsung BioLogics Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biosimilars Products Offered
11.1.5 Pfizer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Biosimilars Market Estimates and Projections by Region
12.1.1 Global Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biosimilars Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biosimilars Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Biosimilars Market Segments
Table 2. Ranking of Global Top Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilars Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Table 5. Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Table 6. Major Manufacturers of Peptides (Glucagon, Calcitonin)
Table 7. COVID-19 Impact Global Market: (Four Biosimilars Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biosimilars Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biosimilars Players to Combat Covid-19 Impact
Table 12. Global Biosimilars Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Biosimilars Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Biosimilars Sales by Regions 2015-2020 (K MT)
Table 15. Global Biosimilars Sales Market Share by Regions (2015-2020)
Table 16. Global Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Biosimilars Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Biosimilars Sales Share by Manufacturers (2015-2020)
Table 19. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2019)
Table 21. Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Biosimilars Price (2015-2020) (USD/MT)
Table 24. Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Biosimilars Product Type
Table 26. Date of International Manufacturers Enter into Biosimilars Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilars Sales by Type (2015-2020) (K MT)
Table 29. Global Biosimilars Sales Share by Type (2015-2020)
Table 30. Global Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Biosimilars Revenue Share by Type (2015-2020)
Table 32. Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Biosimilars Sales by Application (2015-2020) (K MT)
Table 34. Global Biosimilars Sales Share by Application (2015-2020)
Table 35. North America Biosimilars Sales by Country (2015-2020) (K MT)
Table 36. North America Biosimilars Sales Market Share by Country (2015-2020)
Table 37. North America Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Biosimilars Revenue Market Share by Country (2015-2020)
Table 39. North America Biosimilars Sales by Type (2015-2020) (K MT)
Table 40. North America Biosimilars Sales Market Share by Type (2015-2020)
Table 41. North America Biosimilars Sales by Application (2015-2020) (K MT)
Table 42. North America Biosimilars Sales Market Share by Application (2015-2020)
Table 43. Europe Biosimilars Sales by Country (2015-2020) (K MT)
Table 44. Europe Biosimilars Sales Market Share by Country (2015-2020)
Table 45. Europe Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Biosimilars Revenue Market Share by Country (2015-2020)
Table 47. Europe Biosimilars Sales by Type (2015-2020) (K MT)
Table 48. Europe Biosimilars Sales Market Share by Type (2015-2020)
Table 49. Europe Biosimilars Sales by Application (2015-2020) (K MT)
Table 50. Europe Biosimilars Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Biosimilars Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Biosimilars Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Biosimilars Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Biosimilars Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Biosimilars Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Biosimilars Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Biosimilars Sales Market Share by Application (2015-2020)
Table 59. Latin America Biosimilars Sales by Country (2015-2020) (K MT)
Table 60. Latin America Biosimilars Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Biosimilars Revenue Market Share by Country (2015-2020)
Table 63. Latin America Biosimilars Sales by Type (2015-2020) (K MT)
Table 64. Latin America Biosimilars Sales Market Share by Type (2015-2020)
Table 65. Latin America Biosimilars Sales by Application (2015-2020) (K MT)
Table 66. Latin America Biosimilars Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Biosimilars Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Biosimilars Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Biosimilars Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Biosimilars Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Biosimilars Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Biosimilars Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Biosimilars Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Major Businesses
Table 77. Pfizer Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Product
Table 79. Pfizer Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Major Businesses
Table 82. Novartis Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novartis Product
Table 84. Novartis Recent Development
Table 85. Teva Pharmaceuticals Industries Corporation Information
Table 86. Teva Pharmaceuticals Industries Description and Major Businesses
Table 87. Teva Pharmaceuticals Industries Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceuticals Industries Product
Table 89. Teva Pharmaceuticals Industries Recent Development
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Major Businesses
Table 92. Amgen Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Product
Table 94. Amgen Recent Development
Table 95. Biocon Corporation Information
Table 96. Biocon Description and Major Businesses
Table 97. Biocon Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Biocon Product
Table 99. Biocon Recent Development
Table 100. Dr. Reddy’s Laboratories Corporation Information
Table 101. Dr. Reddy’s Laboratories Description and Major Businesses
Table 102. Dr. Reddy’s Laboratories Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dr. Reddy’s Laboratories Product
Table 104. Dr. Reddy’s Laboratories Recent Development
Table 105. Roche Holding Corporation Information
Table 106. Roche Holding Description and Major Businesses
Table 107. Roche Holding Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Holding Product
Table 109. Roche Holding Recent Development
Table 110. Celltrion Corporation Information
Table 111. Celltrion Description and Major Businesses
Table 112. Celltrion Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Celltrion Product
Table 114. Celltrion Recent Development
Table 115. Samsung BioLogics Corporation Information
Table 116. Samsung BioLogics Description and Major Businesses
Table 117. Samsung BioLogics Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Samsung BioLogics Product
Table 119. Samsung BioLogics Recent Development
Table 120. Global Biosimilars Sales Forecast by Regions (2021-2026) (K MT)
Table 121. Global Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 125. North America: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 127. Europe: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Biosimilars Sales Forecast by Region (2021-2026) (K MT)
Table 129. Asia Pacific: Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 131. Latin America: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 133. Middle East and Africa: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Biosimilars Players
Table 138. Biosimilars Customers List
Table 139. Biosimilars Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 1. Biosimilars Market Segments
Table 2. Ranking of Global Top Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilars Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Table 5. Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Table 6. Major Manufacturers of Peptides (Glucagon, Calcitonin)
Table 7. COVID-19 Impact Global Market: (Four Biosimilars Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biosimilars Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biosimilars Players to Combat Covid-19 Impact
Table 12. Global Biosimilars Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Biosimilars Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Biosimilars Sales by Regions 2015-2020 (K MT)
Table 15. Global Biosimilars Sales Market Share by Regions (2015-2020)
Table 16. Global Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Biosimilars Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Biosimilars Sales Share by Manufacturers (2015-2020)
Table 19. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2019)
Table 21. Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Biosimilars Price (2015-2020) (USD/MT)
Table 24. Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Biosimilars Product Type
Table 26. Date of International Manufacturers Enter into Biosimilars Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilars Sales by Type (2015-2020) (K MT)
Table 29. Global Biosimilars Sales Share by Type (2015-2020)
Table 30. Global Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Biosimilars Revenue Share by Type (2015-2020)
Table 32. Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Biosimilars Sales by Application (2015-2020) (K MT)
Table 34. Global Biosimilars Sales Share by Application (2015-2020)
Table 35. North America Biosimilars Sales by Country (2015-2020) (K MT)
Table 36. North America Biosimilars Sales Market Share by Country (2015-2020)
Table 37. North America Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Biosimilars Revenue Market Share by Country (2015-2020)
Table 39. North America Biosimilars Sales by Type (2015-2020) (K MT)
Table 40. North America Biosimilars Sales Market Share by Type (2015-2020)
Table 41. North America Biosimilars Sales by Application (2015-2020) (K MT)
Table 42. North America Biosimilars Sales Market Share by Application (2015-2020)
Table 43. Europe Biosimilars Sales by Country (2015-2020) (K MT)
Table 44. Europe Biosimilars Sales Market Share by Country (2015-2020)
Table 45. Europe Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Biosimilars Revenue Market Share by Country (2015-2020)
Table 47. Europe Biosimilars Sales by Type (2015-2020) (K MT)
Table 48. Europe Biosimilars Sales Market Share by Type (2015-2020)
Table 49. Europe Biosimilars Sales by Application (2015-2020) (K MT)
Table 50. Europe Biosimilars Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Biosimilars Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Biosimilars Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Biosimilars Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Biosimilars Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Biosimilars Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Biosimilars Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Biosimilars Sales Market Share by Application (2015-2020)
Table 59. Latin America Biosimilars Sales by Country (2015-2020) (K MT)
Table 60. Latin America Biosimilars Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Biosimilars Revenue Market Share by Country (2015-2020)
Table 63. Latin America Biosimilars Sales by Type (2015-2020) (K MT)
Table 64. Latin America Biosimilars Sales Market Share by Type (2015-2020)
Table 65. Latin America Biosimilars Sales by Application (2015-2020) (K MT)
Table 66. Latin America Biosimilars Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Biosimilars Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Biosimilars Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Biosimilars Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Biosimilars Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Biosimilars Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Biosimilars Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Biosimilars Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Major Businesses
Table 77. Pfizer Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Product
Table 79. Pfizer Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Major Businesses
Table 82. Novartis Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Novartis Product
Table 84. Novartis Recent Development
Table 85. Teva Pharmaceuticals Industries Corporation Information
Table 86. Teva Pharmaceuticals Industries Description and Major Businesses
Table 87. Teva Pharmaceuticals Industries Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceuticals Industries Product
Table 89. Teva Pharmaceuticals Industries Recent Development
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Major Businesses
Table 92. Amgen Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Product
Table 94. Amgen Recent Development
Table 95. Biocon Corporation Information
Table 96. Biocon Description and Major Businesses
Table 97. Biocon Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Biocon Product
Table 99. Biocon Recent Development
Table 100. Dr. Reddy’s Laboratories Corporation Information
Table 101. Dr. Reddy’s Laboratories Description and Major Businesses
Table 102. Dr. Reddy’s Laboratories Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Dr. Reddy’s Laboratories Product
Table 104. Dr. Reddy’s Laboratories Recent Development
Table 105. Roche Holding Corporation Information
Table 106. Roche Holding Description and Major Businesses
Table 107. Roche Holding Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Holding Product
Table 109. Roche Holding Recent Development
Table 110. Celltrion Corporation Information
Table 111. Celltrion Description and Major Businesses
Table 112. Celltrion Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Celltrion Product
Table 114. Celltrion Recent Development
Table 115. Samsung BioLogics Corporation Information
Table 116. Samsung BioLogics Description and Major Businesses
Table 117. Samsung BioLogics Biosimilars Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Samsung BioLogics Product
Table 119. Samsung BioLogics Recent Development
Table 120. Global Biosimilars Sales Forecast by Regions (2021-2026) (K MT)
Table 121. Global Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 125. North America: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 127. Europe: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Biosimilars Sales Forecast by Region (2021-2026) (K MT)
Table 129. Asia Pacific: Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 131. Latin America: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Biosimilars Sales Forecast by Country (2021-2026) (K MT)
Table 133. Middle East and Africa: Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Biosimilars Players
Table 138. Biosimilars Customers List
Table 139. Biosimilars Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Biosimilars Product Picture
Figure 2. Global Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 4. Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure 5. Peptides (Glucagon, Calcitonin) Product Picture
Figure 6. Global Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Blood Disorders
Figure 9. Biosimilars Report Years Considered
Figure 10. Global Biosimilars Market Size 2015-2026 (US$ Million)
Figure 11. Global Biosimilars Sales 2015-2026 (K MT)
Figure 12. Global Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Biosimilars Sales Market Share by Region (2015-2020)
Figure 14. Global Biosimilars Sales Market Share by Region in 2019
Figure 15. Global Biosimilars Revenue Market Share by Region (2015-2020)
Figure 16. Global Biosimilars Revenue Market Share by Region in 2019
Figure 17. Global Biosimilars Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Biosimilars Revenue in 2019
Figure 19. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Biosimilars Sales Market Share by Type (2015-2020)
Figure 21. Global Biosimilars Sales Market Share by Type in 2019
Figure 22. Global Biosimilars Revenue Market Share by Type (2015-2020)
Figure 23. Global Biosimilars Revenue Market Share by Type in 2019
Figure 24. Global Biosimilars Market Share by Price Range (2015-2020)
Figure 25. Global Biosimilars Sales Market Share by Application (2015-2020)
Figure 26. Global Biosimilars Sales Market Share by Application in 2019
Figure 27. Global Biosimilars Revenue Market Share by Application (2015-2020)
Figure 28. Global Biosimilars Revenue Market Share by Application in 2019
Figure 29. North America Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Biosimilars Sales Market Share by Country in 2019
Figure 32. North America Biosimilars Revenue Market Share by Country in 2019
Figure 33. U.S. Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Biosimilars Market Share by Type in 2019
Figure 38. North America Biosimilars Market Share by Application in 2019
Figure 39. Europe Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Biosimilars Sales Market Share by Country in 2019
Figure 42. Europe Biosimilars Revenue Market Share by Country in 2019
Figure 43. Germany Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Biosimilars Market Share by Type in 2019
Figure 54. Europe Biosimilars Market Share by Application in 2019
Figure 55. Asia Pacific Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Biosimilars Sales Market Share by Region in 2019
Figure 58. Asia Pacific Biosimilars Revenue Market Share by Region in 2019
Figure 59. China Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Biosimilars Market Share by Type in 2019
Figure 82. Asia Pacific Biosimilars Market Share by Application in 2019
Figure 83. Latin America Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Biosimilars Sales Market Share by Country in 2019
Figure 86. Latin America Biosimilars Revenue Market Share by Country in 2019
Figure 87. Mexico Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Biosimilars Market Share by Type in 2019
Figure 94. Latin America Biosimilars Market Share by Application in 2019
Figure 95. Middle East and Africa Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Biosimilars Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Biosimilars Revenue Market Share by Country in 2019
Figure 99. Turkey Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Biosimilars Market Share by Type in 2019
Figure 106. Middle East and Africa Biosimilars Market Share by Application in 2019
Figure 107. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Teva Pharmaceuticals Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Roche Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Samsung BioLogics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Figure 1. Biosimilars Product Picture
Figure 2. Global Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 4. Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure 5. Peptides (Glucagon, Calcitonin) Product Picture
Figure 6. Global Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Blood Disorders
Figure 9. Biosimilars Report Years Considered
Figure 10. Global Biosimilars Market Size 2015-2026 (US$ Million)
Figure 11. Global Biosimilars Sales 2015-2026 (K MT)
Figure 12. Global Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Biosimilars Sales Market Share by Region (2015-2020)
Figure 14. Global Biosimilars Sales Market Share by Region in 2019
Figure 15. Global Biosimilars Revenue Market Share by Region (2015-2020)
Figure 16. Global Biosimilars Revenue Market Share by Region in 2019
Figure 17. Global Biosimilars Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Biosimilars Revenue in 2019
Figure 19. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Biosimilars Sales Market Share by Type (2015-2020)
Figure 21. Global Biosimilars Sales Market Share by Type in 2019
Figure 22. Global Biosimilars Revenue Market Share by Type (2015-2020)
Figure 23. Global Biosimilars Revenue Market Share by Type in 2019
Figure 24. Global Biosimilars Market Share by Price Range (2015-2020)
Figure 25. Global Biosimilars Sales Market Share by Application (2015-2020)
Figure 26. Global Biosimilars Sales Market Share by Application in 2019
Figure 27. Global Biosimilars Revenue Market Share by Application (2015-2020)
Figure 28. Global Biosimilars Revenue Market Share by Application in 2019
Figure 29. North America Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Biosimilars Sales Market Share by Country in 2019
Figure 32. North America Biosimilars Revenue Market Share by Country in 2019
Figure 33. U.S. Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Biosimilars Market Share by Type in 2019
Figure 38. North America Biosimilars Market Share by Application in 2019
Figure 39. Europe Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Biosimilars Sales Market Share by Country in 2019
Figure 42. Europe Biosimilars Revenue Market Share by Country in 2019
Figure 43. Germany Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Biosimilars Market Share by Type in 2019
Figure 54. Europe Biosimilars Market Share by Application in 2019
Figure 55. Asia Pacific Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Biosimilars Sales Market Share by Region in 2019
Figure 58. Asia Pacific Biosimilars Revenue Market Share by Region in 2019
Figure 59. China Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Biosimilars Market Share by Type in 2019
Figure 82. Asia Pacific Biosimilars Market Share by Application in 2019
Figure 83. Latin America Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Biosimilars Sales Market Share by Country in 2019
Figure 86. Latin America Biosimilars Revenue Market Share by Country in 2019
Figure 87. Mexico Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Biosimilars Market Share by Type in 2019
Figure 94. Latin America Biosimilars Market Share by Application in 2019
Figure 95. Middle East and Africa Biosimilars Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Biosimilars Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Biosimilars Revenue Market Share by Country in 2019
Figure 99. Turkey Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Biosimilars Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Biosimilars Market Share by Type in 2019
Figure 106. Middle East and Africa Biosimilars Market Share by Application in 2019
Figure 107. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Teva Pharmaceuticals Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Roche Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Samsung BioLogics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Biosimilars Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
